TMCnet - World's Largest Communications and Technology Community



Cytokinetics Down 5.3%, Shares Slide into the Red (CYTK)
[April 03, 2013]

Cytokinetics Down 5.3%, Shares Slide into the Red (CYTK)

Apr 03, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Cytokinetics (NASDAQ:CYTK) is one of today's worst performing low-priced stocks, down 5.3% to $1.07 on 1.0x average daily volume. Cytokinetics has traded 775,000 shares thus far today, vs. average volume of 742,000 shares per day. The stock has underperformed the Dow (-5.3% to the Dow's -0.3%) and underperformed the S&P 500 (-5.3% to the S&P's -0.5%) during today's trading.

There is potential upside of 245.8% for shares of Cytokinetics based on a current price of $1.07 and an average consensus analyst price target of $3.70. The stock should find initial support at its 50-day moving average (MA) of $1.06 and further support at its 200-day MA of $0.82.

Cytokinetics, Incorporated is a biopharmaceutical company that combines life sciences and information technologies to accelerate and enhance the productivity of drug discovery and development. The Company focuses on the novel small molecule drugs that specifically target the cytoskeleton, a complex, dynamic framework that impacts all aspects of cell functions.

Over the past year, Cytokinetics has traded in a range of $0.57 to $1.28 and is now at $1.07, 88% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has risen 0.4%.

SmarTrend recommended that subscribers consider buying shares of Cytokinetics on January 7th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $0.82. Since that recommendation, shares of Cytokinetics have risen 37.8%. We continue to monitor CYTK for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy